Dr. Arthur “Buzz” Brown

News

ChanRx to use $250K investment to reformulate a-fib drug

Updated 2:47 p.m., Aug. 5, 2010. Two-year-old drug development company ChanRx has received a $250,000 investment commitment from JumpStart Ventures, the investment arm of Northeast Ohio venture developer JumpStart Inc. ChanRx was spun off by ChanTest Corp. in Garfield Heights, Ohio, to develop small-molecule drugs — specifically, Vanoxerine — to treat atrial fibrillation, an increasingly […]

By Mary Vanac

Top Story

ChanTest acquisition of Applied Cell Sciences: ‘the perfect fit’

Dr. Arthur "Buzz" Brown describes his company's acquisition of a Rockville, Md., contract research organization as a 1-plus-1-equals-5 kind of deal. Last week, ChanTest acquired Applied Cell Sciences in Rockville, Md., for undisclosed terms.

By Mary Vanac

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.

Physicians

OmniLife Health’s Clinical Workflow Solution Focuses on Complex Care

OmniLife Health's initial focus with its complex care coordination platform is organ transplant care.

Health Tech

HealthBook+ CEO Shares Vision for How People Can Own Their Health by Leveraging Data and AI

HealthBook+ provides a way for individuals to aggregate and use their personal health information safely and securely to power AI engines that direct people to their next best health action. Importantly, it also gives employers predictive insights to help them provide the most relevant benefits for their employees.